Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
RTS,S vaccine (Mosquirix) (GSK257049)
Also known as: Malaria vaccine
print preview
bookmark
share with colleague
General Information
Company
GlaxoSmithKline plc
Description
Malaria vaccine targeting the circumsporozoite protein (CSP) combined with the AS01 adjuvant
Molecular Target
Mechanism of Action
Vaccine
Latest Stage of Development
Phase III
Indication
Malaria
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy